BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
111 – 120 of 3088
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
(
- Contribution to journal › Letter
-
Mark
A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors
(
- Contribution to journal › Article
-
Mark
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis
2019) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28(5). p.935-942(
- Contribution to journal › Article
-
Mark
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study
2019) In European Radiology Experimental(
- Contribution to journal › Article
-
Mark
Incidental metastases and lymphoma of the gallbladder–an analysis of ten rare cases identified from a large national database
(
- Contribution to journal › Article
-
Mark
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study) : Protocol for a multicenter phase II open label study
(
- Contribution to journal › Article
-
Mark
Comparison of Voxel-Wise and Histogram Analyses of Glioma ADC Maps for Prediction of Early Therapeutic Change
(
- Contribution to journal › Article
-
Mark
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
(
- Contribution to journal › Article
-
Mark
Population-based primary HPV mRNA cervical screening compared with cytology screening
(
- Contribution to journal › Article
-
Mark
Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
(
- Contribution to journal › Article